[go: up one dir, main page]

MX9804419A - Receptor polipeptidico de il-i3. - Google Patents

Receptor polipeptidico de il-i3.

Info

Publication number
MX9804419A
MX9804419A MX9804419A MX9804419A MX9804419A MX 9804419 A MX9804419 A MX 9804419A MX 9804419 A MX9804419 A MX 9804419A MX 9804419 A MX9804419 A MX 9804419A MX 9804419 A MX9804419 A MX 9804419A
Authority
MX
Mexico
Prior art keywords
receptor polypeptide
seq
amino acid
disclosed
biologically active
Prior art date
Application number
MX9804419A
Other languages
English (en)
Inventor
Daniel Caput
Pascual Ferrara
Patrick Laurent
Natalio Vita
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9485198&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9804419(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MX9804419A publication Critical patent/MX9804419A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a un polipéptido purificado que comprende una secuencia de aminoácidos escogida entre: a) la secuencia SEQ ID n.2, b) cualquier secuencia biologicamente activa derivada de SEQ ID n.2.
MX9804419A 1995-12-06 1998-06-03 Receptor polipeptidico de il-i3. MX9804419A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9514424A FR2742156A1 (fr) 1995-12-06 1995-12-06 Polypeptide recepteur de l'il-13

Publications (1)

Publication Number Publication Date
MX9804419A true MX9804419A (es) 1998-09-30

Family

ID=9485198

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9804419A MX9804419A (es) 1995-12-06 1998-06-03 Receptor polipeptidico de il-i3.

Country Status (19)

Country Link
US (4) US20060035856A1 (es)
EP (1) EP0876482B1 (es)
JP (3) JP3415162B2 (es)
AR (2) AR004860A1 (es)
AT (1) ATE234922T1 (es)
AU (1) AU7576096A (es)
BR (1) BR9611697B1 (es)
CA (1) CA2238893C (es)
DE (1) DE69626859T2 (es)
DK (1) DK0876482T3 (es)
ES (1) ES2192620T3 (es)
FR (1) FR2742156A1 (es)
MX (1) MX9804419A (es)
MY (1) MY123740A (es)
NO (3) NO324775B1 (es)
PT (1) PT876482E (es)
TW (1) TW565570B (es)
WO (1) WO1997020926A1 (es)
ZA (1) ZA9610238B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911530B1 (en) 1995-10-23 2005-06-28 Amrad Operations, Pty., Ltd. Haemopoietin receptor and genetic sequences encoding same
ATE445011T1 (de) * 1995-10-23 2009-10-15 Zenyth Operations Pty Ltd Hemopoietin-rezeptor und dafür kodierende genetische sequenzen
US5710023A (en) 1996-03-01 1998-01-20 Genetics Institute, Inc. IL-13 cytokine receptor chain
US7078494B1 (en) 1996-03-01 2006-07-18 Genetics Institute, Llc Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding
EP0812913A3 (en) * 1996-06-12 1999-08-04 Smithkline Beecham Corporation HR-1 receptor, a receptor of the cytokine receptors family
WO1998010638A1 (en) * 1996-09-10 1998-03-19 Amrad Operations Pty. Ltd. Therapeutic molecules
GB9625899D0 (en) * 1996-12-13 1997-01-29 Glaxo Group Ltd Substances and their uses
US6743604B1 (en) 1996-12-13 2004-06-01 Smithkline Beecham Corporation Substances and their uses
US7198789B2 (en) 1998-03-17 2007-04-03 Genetics Institute, Llc Methods and compositions for modulating interleukin-21 receptor activity
US7189400B2 (en) 1998-03-17 2007-03-13 Genetics Institute, Llc Methods of treatment with antagonists of MU-1
US6057128A (en) 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
CA2235420A1 (en) * 1998-06-17 1999-12-17 Paolo Renzi Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
ATE342976T1 (de) * 1998-12-14 2006-11-15 Genetics Inst Llc Cytokinrezeptor-kette
EP1257289A1 (en) * 2000-02-08 2002-11-20 The Penn State Research Foundation Immunotherapy using interleukin 13 receptor subunit alpha 2
WO2001077332A2 (en) * 2000-04-07 2001-10-18 Heska Corporation Compositions and methods related to canine igg and canine il-13 receptors
MXPA05000655A (es) 2002-07-15 2006-02-22 Harvard College Metodos y composiciones para modular el desarrollo y la funcion de las celulas t helper (th).
HUE064610T2 (hu) 2003-12-23 2024-04-28 Genentech Inc Új anti-IL 13 antitestek és alkalmazásaik
US20090098142A1 (en) * 2004-06-09 2009-04-16 Kasaian Marion T Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
EP1812075B1 (en) 2004-10-29 2013-12-11 Topigen Pharmaceuticals Inc. Antisense oligonucleotides for treating allergy and neoplastic cell proliferation
MX2007005866A (es) 2004-11-17 2007-11-12 Amgen Inc Anticuerpos monoclonales totalmente humanos para il-13.
GB0615881D0 (en) * 2006-08-10 2006-09-20 Univ Southampton Novel peptide for treatment of asthma
CA2685123A1 (en) * 2007-04-23 2008-10-30 Wyeth Methods and compositions for treating and monitoring treatment of il-13-associated disorders
US9512194B2 (en) 2012-01-27 2016-12-06 The Board Of Trustees Of The Leland Stanford Junior University Modified IL-13 polypeptides
CN104619334A (zh) 2012-08-09 2015-05-13 利兰斯坦福初级大学董事会 超级因子和合成因子:具有新的和增强的信号传导活性的经改造细胞因子
PL2970492T3 (pl) * 2013-03-15 2019-10-31 Univ Wake Forest Health Sciences Przeciwciała przeciwko ludzkim i psim il-13ra2
IL320195A (en) 2013-09-13 2025-06-01 Genentech Inc Methods and compositions containing purified recombinant polypeptides
WO2015038884A2 (en) 2013-09-13 2015-03-19 Genentech, Inc. Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products
EP3049525B1 (en) 2013-09-24 2025-07-23 Medicenna Therapeutics, Inc. Interleukin-4 receptor-binding fusion proteins and uses thereof
US12274735B2 (en) 2017-10-10 2025-04-15 Medicenna Therapeutics Inc. IL-4-fusion formulations for treatment of central nervous system (CNS) tumors
US12404497B2 (en) 2018-06-01 2025-09-02 Medicenna Therapeutics Inc. Uses and methods for oncolytic virus targeting of IL-4/IL-13 and fusions thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
ES2136092T3 (es) * 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
US5596072A (en) 1992-08-21 1997-01-21 Schering Corporation Method of refolding human IL-13
US5587459A (en) * 1994-08-19 1996-12-24 Regents Of The University Of Minnesota Immunoconjugates comprising tyrosine kinase inhibitors
US6911530B1 (en) * 1995-10-23 2005-06-28 Amrad Operations, Pty., Ltd. Haemopoietin receptor and genetic sequences encoding same
US5710023A (en) 1996-03-01 1998-01-20 Genetics Institute, Inc. IL-13 cytokine receptor chain

Also Published As

Publication number Publication date
DE69626859D1 (de) 2003-04-24
JP3737793B2 (ja) 2006-01-25
NO982550L (no) 1998-08-05
NO20092994L (no) 1998-08-05
NO982550D0 (no) 1998-06-04
EP0876482B1 (fr) 2003-03-19
CA2238893C (fr) 2013-10-08
US20110201029A1 (en) 2011-08-18
US20060035855A1 (en) 2006-02-16
NO328197B1 (no) 2010-01-04
AU7576096A (en) 1997-06-27
US20060035856A1 (en) 2006-02-16
NO20074034L (no) 1998-08-05
NO324775B1 (no) 2007-12-10
US8318910B2 (en) 2012-11-27
NO331148B1 (no) 2011-10-24
JPH11511028A (ja) 1999-09-28
DK0876482T3 (da) 2003-07-21
TW565570B (en) 2003-12-11
ES2192620T3 (es) 2003-10-16
MY123740A (en) 2006-06-30
EP0876482A1 (fr) 1998-11-11
WO1997020926A1 (fr) 1997-06-12
ZA9610238B (en) 1998-06-05
FR2742156A1 (fr) 1997-06-13
AR004860A1 (es) 1999-03-10
BR9611697A (pt) 1999-02-17
US20050282216A1 (en) 2005-12-22
JP3415162B2 (ja) 2003-06-09
PT876482E (pt) 2003-07-31
CA2238893A1 (fr) 1997-06-12
US7928073B2 (en) 2011-04-19
ATE234922T1 (de) 2003-04-15
JP4185070B2 (ja) 2008-11-19
AR056723A2 (es) 2007-10-17
JP2003180382A (ja) 2003-07-02
DE69626859T2 (de) 2003-12-24
BR9611697B1 (pt) 2013-09-17
JP2005323595A (ja) 2005-11-24

Similar Documents

Publication Publication Date Title
MX9804419A (es) Receptor polipeptidico de il-i3.
NZ507378A (en) Fusion proteins of mycobacterium tuberculosis antigens and their uses
PT1165791E (pt) Citocina humana como ligando do receptor zalpha e seus usos
AU2001290837A1 (en) Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation
HU9502466D0 (en) Novel pesticidal proteins and strains
NZ503850A (en) April - a novel protein with growth effects
AU8635391A (en) Nucleotide sequences coding for a human protein with angiogenesis regulative properties
CA2551182A1 (en) Novel kappa receptor selective opioid peptides
EP0962531A3 (en) Interferon-gamma production inducing isolated polypeptide fragment and an isolated DNA fragment encoding said polypeptide
WO1996038473A3 (en) Antimicrobial cationic peptides
NZ332255A (en) Use of herpes simplex virus glycoprotein d variants
IL141869A0 (en) Mammalian transforming growth factor beta-9 (ztgfss9)
EP1006126A3 (en) Osteogenic peptides
MX9708792A (es) Gen de ataxia-telangiectasia.
AU1431188A (en) Dihydropyridine - pyridinium salt-type redox amino acids and peptides containing them
WO1997012963A3 (en) A paf-acetylhydrolase and use in therapy
HU9601232D0 (en) Tomato xyloglucan endo-transglicosylase
CA2302551A1 (en) .beta.-fructofuranosidase and its gene
EP0643075A4 (en) NEW PEPTIDES WITH ELASTASE INHIBITOR EFFECT AND METHOD FOR THE PRODUCTION THEREOF.
DE59806878D1 (de) Peptid mit affinität zu gerinnungsfaktor viii
GB9416536D0 (en) Orphan receptor
NZ320932A (en) Short forms of chemokine b-8
NZ508812A (en) Peptides for the prevention or treatment of HIV
AU773969C (en) Novel tachykinin peptides, precursor peptides thereof and genes encoding the same
GB2361923A (en) Novel protein

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights
HC Change of company name or juridical status
HC Change of company name or juridical status